Assessment of Immune Responses Against AAV Encoded Transgene Products
Authors:
- Boris GorovitsBGBoris Gorovits
- Mitra AzadehMAMitra Azadeh
- Michele FiscellaMFMichele Fiscella
- Travis HarrisonTHTravis Harrison
- Magdalena HoferMHMagdalena Hofer
- Sylvia JanetzkiSJSylvia Janetzki
- Vibha JawaVJVibha Jawa
- Brian LongBLBrian Long
- Yanmei LuYLYanmei Lu
- Yolanda D. MahnkeYMYolanda D. Mahnke
- Mauricio MaiaMMMauricio Maia
- Ritankar MajumdarRMRitankar Majumdar
- 5 January 2026
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (1) , 43
Abstract
The number of clinical investigations and approved applications of adeno-associated virus (AAV) based transgene product (TP) delivery has grown steadily. TKeywords
This publication has 178 references indexed in Scilit:
- Important Considerations for ELISpot Validation2024
- Ensuring Full Spectrum Flow Cytometry Data Quality for High‐Dimensional Data AnalysisCurrent Protocols, 2023
- Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMDClinical and Translational Medicine, 2022
- Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI)Cytometry Part A, 2020
- Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophyPediatric Pulmonology, 2020
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)European Journal of Immunology, 2019
- CytoNorm: A Normalization Algorithm for Cytometry DataCytometry Part A, 2019
- Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene deliveryThe Journal of Gene Medicine, 2013
- Predicting cross‐reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experienceAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012
- A Deviant Immune Response to Viral Proteins and Transgene Product Is Generated on Subretinal Administration of Adenovirus and Adeno-associated VirusMolecular Therapy, 2002